1 results match your criteria: "Ferrol University Clinical Hospital[Affiliation]"
Identifying advanced MAFLD in a cohort of T2DM and clinical features.
Front Endocrinol (Lausanne)
March 2023
Division of Endocrinology and Nutrition, Ferrol University Clinical Hospital, Ferrol, Spain.
Background: MAFLD is the most common cause of chronic liver disease, affecting 25% of the global population. Patients with T2DM have an increased risk of developing MAFLD. In addition, patients with T2DM have a higher risk of advanced forms of steatohepatitis and fibrosis.
View Article and Find Full Text PDF